+ Watch SGNT
on My Watchlist
Low-risk diversification strategy across multiple drugs.
Looks like its consolidating from the S&P downgrade. The price just moved above its 50 day lin reg line so I bet in a few weeks it will regress back to it.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions